tioconazole + tinidazole

Tioconazole + tinidazole is a fixed-dose combination drug used primarily for the treatment of mixed vaginal infections, including bacterial vaginosis, candidal vulvovaginitis (yeast infections), trichomonal vaginitis, and other mixed infections. Tioconazole is an imidazole antifungal that inhibits fungal cell membrane synthesis by targeting 14-α demethylase (a cytochrome P-450 enzyme), resulting in increased membrane permeability and cell death. Its spectrum covers most Candida species as well as some Gram-positive bacteria. Tinidazole is a nitroimidazole antimicrobial, functioning as an antiprotozoal and antibacterial by disrupting DNA synthesis and integrity in susceptible organisms, particularly anaerobic bacteria and certain protozoa (e.g., Trichomonas vaginalis, Gardnerella vaginalis). The combination targets both fungal and anaerobic/protozoal pathogens frequently implicated in vaginal and mixed genital infections, leveraging both agents' mechanisms for broad coverage and improved patient compliance with once-daily or short-course intravaginal administration.[3][5][7][8]